Locations:
Search IconSearch

Clinical Cardiology

22-HVI-3073724 CQD 650×450

Recurrent Pericarditis: It’s Time to Recognize the Paradigm Shift in Imaging and Therapeutics

Targeted IL-1 blockers and CMR techniques allow more-tailored treatment strategies

22-HVI-3073818_atrial-fibrillation_650x450

Preexisting Atrial Fibrillation Predicts Worse Cardiac Outcomes After Noncardiac Surgery

Large cohort study argues for incorporating AF into perioperative risk scores

01_22Cov1.indd
May 6, 2022/Digestive

Cardiac Considerations for the Liver Transplant Patient

As the demographics of transplant recipients shift, their heart care must keep pace

22-HVI-2769712_hyptertrophic-cardiomyopathy_650x450

Mavacamten Significantly Reduces Patients’ Need for Septal Reduction Therapy Over 16 Weeks

Longer-term confirmation of VALOR-HCM could yield a noninvasive therapy for severe obstructive HCM

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-HVI-2713173_spontaneous-coronary-artery-dissection_650x450

Spontaneous Coronary Artery Dissection: Principles of Management

How Cleveland Clinic approaches the condition in the absence of randomized trial data

21-HVI-2500367-hypertrophic-cardiomyopathy-650×450

In Obstructive Hypertrophic Cardiomyopathy, One Size Does Not Fit All

Why we favor a tailored approach to relieve LVOT obstruction

21-HVI-2360358-cardiogenic-shock-team-650×450

Circulatory Support in Cardiogenic Shock: Weaning Is Just as Important as Initiation

Long-overdue guidance now available on readiness to wean and device explant

21-HVI-2460008-cardiac-virtual-visits-650×450
November 2, 2021/COVID-19

5 Steps to Swiftly Transform a Large Community Cardiology Practice to Virtual Visits

A snapshot of our multisite experience in safely maintaining care during COVID-19

21-HVI-2288859-COVID-19-and-the-heart_650x450
August 18, 2021/COVID-19

Canakinumab for COVID-19 With Cardiac Injury: Early Trial Shapes Strategy for Future Investigation

Three C Study suggests 28-day efficacy window, 600-mg dose

21-HVI-2232209-Methods-Hero-650×450

Study Uncovers Serious Shortcomings of Systematic Reviews in Top Cardiology Journals

Nearly three-quarters found lacking in methodological quality and/or reporting practices

BackPage 3 of 4Next

Advertisement

Ad